Cochrane evidence on managing depression, schizophrenia and autism spectrum disorders

Two more mental health reviews published in Issue 10 in The Cochrane Library are the subject of excellent blogs from The Mental Elf. These new reviews, from the Cochrane Depression, Anxiety and Neurosis Group and the Cochrane Schizophrenia Group, look at the evidence on duloxetine compared with other drugs for depression, and on information and communication technology in patient education and support for people with schizophrenia. A third blog neatly summarises a new review from the Cochrane Developmental, Psychosocial and Learning Problems Group on the effectiveness of Early Intensive Behavioural Intervention for children with autism spectrum disorders, an approach which is widely used with the aim of improving functional behaviours and skills in these children. They’re well worth reading and you can find them from the links below. Continue reading

Advertisements